Wang Lingling, Qian Xing, Yang Min, Wang Xuwen
Wuxi Center for Disease Control and Prevention, The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi, China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2432118. doi: 10.1080/21645515.2024.2432118. Epub 2024 Dec 5.
The aim of this study was to evaluate seroepidemiology of varicella in Wuxi, China, after two doses of immunization of varicella vaccine (VarV) for better control of varicella transmission. Participants were selected randomly by multistage stratified sampling. The positive rate of antibody and geometric antibody titer (GMC) was determined with enzyme-linked immunosorbent assays. Logistic and linear regressions were used to analyze the correlations between antibody seropositivity, GMCs, and corresponding factors. Serum samples ( = 697) were obtained from healthy children <7 years-of-age. Seropositivity and GMC were 67.84% and 190.97 mIU/mL, respectively, in subjects receiving two doses of VarV. Multivariate analysis revealed that both the rate of varicella-zoster virus immunoglobulin G seropositivity and GMC in vaccinated subjects were higher compared to those who had not been vaccinated. The strongest overall response was observed in subjects with two doses of VarV (4.055, 95% CI: 2.774 ~ 5.928). In 470 subjects with a history of VarV application, the antibody GMC value was reduced 4 years after vaccination. Two-dose vaccination with VarV was an effective prevention strategy varicella and should be included in a national immunization program.
本研究旨在评估在中国无锡对水痘疫苗(VarV)进行两剂免疫接种后水痘的血清流行病学情况,以更好地控制水痘传播。通过多阶段分层抽样随机选择参与者。采用酶联免疫吸附测定法测定抗体阳性率和几何抗体滴度(GMC)。使用逻辑回归和线性回归分析抗体血清阳性率、GMC与相应因素之间的相关性。从7岁以下健康儿童中获取血清样本(n = 697)。接受两剂VarV的受试者中,血清阳性率和GMC分别为67.84%和190.97 mIU/mL。多变量分析显示,与未接种疫苗的受试者相比,接种疫苗的受试者中水痘-带状疱疹病毒免疫球蛋白G血清阳性率和GMC均更高。在接受两剂VarV的受试者中观察到最强的总体反应(4.055,95%CI:2.774~5.928)。在470名有VarV接种史的受试者中,接种疫苗4年后抗体GMC值降低。两剂VarV接种是预防水痘的有效策略,应纳入国家免疫规划。